VivaQuity Ltd. is a wholly–owned subsidiary of ebiga-VISION, based in Waterford, Ireland, strategically located near one of the world’s leading centres for vision and nutrition research. With a dedicated presence in the UK, we ensure close collaboration and direct communication with local healthcare professionals, as well as distributors and partners.
The FLIES study is the first randomised, double-blind, placebo-controlled clinical trial to assess the impact of targeted nutritional supplementation on vitreous floaters. The trial included 61 patients aged 18-79 years. After 6 months of supplementation with VitroCap®N, 77% of patients experienced a reduction in vitreous opacity areas.
In 2025 we will be exhibiting at optometry and ophthalmology conferences in the UK, Ireland, and the USA. Big or small, each of these events is a unique opportunity to meet dedicated, education-driven eye care professionals. We look forward to seeing more of you!
ebiga-Vision is a company specializing in vision science, committed to diagnosing, preventing, and treating eye conditions and chronic diseases affecting vision. With a focus on research and development, ebiga-Vision also offers nutritional supplements designed to meet the specific micronutrient needs of the eyes. The company’s current areas of focus include vitreous degeneration, diabetes-related eye conditions, macular degeneration, and glaucoma.
Tested effectiveness on floaters
For diabetic eyes
For the maintenance of vision and normal functioning of the nervous system.
Premium complex for eyesight + vitality
Basic nutritional care for the macula
AREDS2 upgrade with meso-zeaxanthin
